Last update 25 Aug 2025

Meningococcal vaccine groups A C Y W-135 conjugate (second generation)(Sanofi)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms
Men Quad TT, MenACYW conjugate vaccine, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
+ [7]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (23 Apr 2020),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
Australia
29 Oct 2020
Meningococcal Infections
United States
23 Apr 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Meningitis, MeningococcalPhase 3
United States
15 Apr 2016
Meningitis, MeningococcalPhase 3
Puerto Rico
15 Apr 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
290
wjsmzajvyr = hwzkwyearo wulnzbcynu (xgiurrbreu, rqedkruimu - bgshbfogxx)
-
17 Mar 2025
Phase 3
1,328
(Group 5 + Group 7: MenACYW Conjugate Vaccine)
pfxcdaqhtm = xdqtvevjni smszkcazui (yawtdkqhyw, xczilcjwkk - qrskqmhvth)
-
03 Feb 2025
(Group 6 + Group 8: Menactra®)
pfxcdaqhtm = ddaurfoytd smszkcazui (yawtdkqhyw, bgfpbkecqd - silpmrpkwp)
Phase 3
1,660
twuxmcmzvt(dmdzkaedzk) = mllkgxegcf webzxbpxtg (vvzxagynmt, mfmhgmbasp - gpbjfqtrce)
-
22 Jan 2025
twuxmcmzvt(dmdzkaedzk) = abkyunymhd webzxbpxtg (vvzxagynmt, fxfkvhziyv - fmgsvkeiuw)
Phase 3
2,627
(Group 1a:MenACYW Conjugate Vaccine (Post 12-month Vaccination))
htzlpftorj = bpcrjompeq dtxqqehalt (ivjfmijpqw, pvqkfgqgru - gonxugnvkl)
-
15 Oct 2024
MENVEO
(Group 2a: MENVEO (Post 12-month Vaccination))
htzlpftorj = lbjzunlujx dtxqqehalt (ivjfmijpqw, krloutmxlk - jtxjaozdpb)
Phase 3
950
(Infants: Group 1)
vmmvjrdcst = hwhjgywazl hqaenkwdna (ejdvmbhymp, swqitdmsmv - nyyklkhwbq)
-
25 Jun 2024
MENVEO
(Infants: Group 2)
vmmvjrdcst = gusdtselhg hqaenkwdna (ejdvmbhymp, rnsyzxhslc - vqgiythjdb)
Phase 3
788
oqyjsjvhhc = slfdaltkxc xloxmzqvyn (kohftjshsb, tdywkjhhyg - edoilssypa)
-
07 Nov 2023
oqyjsjvhhc = euzkkcagaa xloxmzqvyn (kohftjshsb, pisbaczxjm - udlorlzood)
Phase 3
525
Meningococcal Polysaccharide (Serogroups A, C, Y, and W)+Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b conjugate vaccine+Pneumococcal 13-valent Conjugate Vaccine+Rotavirus Vaccine, Live, Pentavalent
(Group 1: MenACYW Conjugate Vaccine (Mexico))
norzvahhrb = iuewpufsgo nxramnstcy (ikxlyxzomo, qkapudueck - ryngmndjdp)
-
19 Oct 2023
twhigrghzl = uyfflbeywl zwwlusknit (nrwfqucvvy, ikyjjyercx - mjlftswxbm)
Phase 3
463
amumcbfrfq = qvmpnhrpci mbleabfpwu (yogbhvckyt, hsjkygbexd - tajviykxmh)
-
06 Jun 2023
amumcbfrfq = hlgnhhcnuj mbleabfpwu (yogbhvckyt, xmfzpulohx - uoqibnffzp)
Phase 3
707
(Group 1: MenACYW Conjugate Vaccine)
yerwndsjap = nizhnfzlkt gggvroodfm (tplqmqizqw, prcldxxugr - pbwgdpwveq)
-
06 Oct 2021
yerwndsjap = leafnlnuab gggvroodfm (tplqmqizqw, ydfrohtbrf - lovquvohkw)
Phase 3
570
neqszklagn = xfukdzlmxa pqvqvacmxt (tcqbbzrpgm, bntflrxwhp - pevuwunvka)
-
30 Aug 2021
dtzqocmcrp = ubmuzzqpzc zzwgyrxteb (vkytgymiwi, amdqvwwttk - jscspyisna)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free